Company has added three broker reports: https://genexpower.com.au/investors/#broker-reports
Cannacord have posted an updated on their broker report, with $0.34 valuation.
Morgans have posted a one para note saying that they are reviewing financials, and noting their May valuation (separate report just posted) of $0.31.
- Forums
- ASX - By Stock
- GNX
- Ann: Q4 FY 22 Investor Presentation Update
Ann: Q4 FY 22 Investor Presentation Update, page-3
Featured News
Add GNX (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online